Categories
Business

Pfizer’s Vaccine Gives Sturdy Safety After First Dose

WASHINGTON – The coronavirus vaccine, manufactured by Pfizer and BioNTech, offers strong protection against Covid-19 within about 10 days of the first dose. This emerges from documents released Tuesday by the Food and Drug Administration ahead of a meeting of their vaccine advisory group.

The result is one of several significant new results in the newsletters, which includes more than 100 pages of data analysis from the Agency and Pfizer. Last month Pfizer and BioNTech announced that their two-dose vaccine had a 95 percent effectiveness rate after two doses three weeks apart. The new analyzes show that protection starts much earlier.

In addition, the vaccine worked well regardless of the race, weight, or age of a volunteer. While no serious adverse events from the vaccine were identified in the study, many participants experienced pain, fever, and other side effects.

“This is what an A + certificate looks like for a vaccine,” said Akiko Iwasaki, an immunologist at Yale University.

On Thursday, the FDA’s Vaccine Advisory Panel will discuss these materials prior to a vote on whether to recommend approval of the vaccine by Pfizer and BioNTech.

Pfizer and BioNTech started a large-scale clinical trial in July that recruited 44,000 people in the US, Brazil and Argentina. Half of the volunteers received the vaccine and half the placebo.

New coronavirus cases in the vaccinated group of volunteers quickly subsided about 10 days after the first dose, according to a graphic in the educational materials. The number of cases increased steadily in the placebo group.

The vaccine’s swift action could benefit not only the people who receive it, but also the strained hospitals in the country, limiting the flow of new patients to intensive care units.

Despite the early protection provided by the first dose, it is unclear how long this protection would last on its own, which underscores the importance of the second dose. Previous studies have shown that the second dose of the Pfizer BioNTech vaccine gives the immune system a significant long-term boost that is seen with many other vaccines.

The effectiveness of the vaccine after the first dose, according to Dr. William C. Gruber, senior vice president of Pfizer Vaccine Clinical Research and Development, at about 52 percent. After the second dose, this value increases to about 95 percent. “Two doses of the vaccine offer maximum protection,” he said.

Many experts have raised concerns that the coronavirus vaccines might protect some people better than others. However, the results in the educational materials indicate no such problem. The vaccine has a high rate of effectiveness in both men and women, and similar rates in whites, blacks, and Latinos. It also worked well on obese people who are at higher risk of developing Covid-19.

Some vaccines for other diseases produce a weak immune response in older adults. However, Pfizer and BioNTech found that people over 65 received about as much protection from the coronavirus vaccine as younger people.

“I’ve never seen anything like it,” said Dr. Gregory Poland, a vaccine researcher at the Mayo Clinic, on the vaccine’s robust response in the overweight and elderly.

Even if the vaccine is approved by the FDA, the study will continue. In the briefing documents, the companies said they would encourage people to stay in the study for as long as possible without knowing whether they received the vaccine or the placebo, so the researchers can continue to gather information on whether the vaccine is safe and effective.

The road to a coronavirus vaccine

Interesting facts about vaccines

Confused by all of the technical terms used to describe how vaccines work and study? Let us help:

    • Adverse event: A health problem that occurs in volunteers in a clinical trial with a vaccine or drug. An adverse event is not always caused by the treatment tested in the study.
    • Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and prevent it from infecting cells.
    • Approval, Licensing, and Approval for Emergency Use: Medicines, vaccines and medical devices cannot be sold in the US for no profit approval by the Food and Drug Administration, also known as Licensing. After a company submits the results of clinical studies to the FDA for review, the agency decides whether the product is safe and effective. This process usually takes many months. If the country faces an emergency – like a pandemic – a company can file an application instead Emergency approvalthat can be granted much faster.
    • Background rate: How often does the general population experience a health problem called an Adverse Event? To determine whether a vaccine or drug is safe, researchers compare the rate of adverse events in one study to the background rate.
    • Effectiveness: The benefit of a vaccine compared to a placebo, measured in a clinical trial. For example, to test a coronavirus vaccine, the researchers compare how many people in the vaccinated group and the placebo group are receiving Covid-19. In contrast, effectiveness is the benefit that a vaccine or drug offers in the real world. A vaccine’s effectiveness can be found to be less or more effective than its effectiveness.
    • Phases 1, 2 and 3 studies: Clinical trials typically take place in three phases. Phase 1 studies typically involve a few dozen people to determine whether a vaccine or drug is safe. In Phase 2 trials that involve hundreds of people, researchers can try different doses and take more measurements of the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and effectiveness of the vaccine or medicine by waiting to see how many people are protected from the disease it is intended to be used against.
    • Placebo: A substance with no therapeutic effect that is widely used in clinical trials. For example, to see if a vaccine can prevent Covid-19, researchers can inject the vaccine into half of their volunteers while the other half are given a placebo with salt water. You can then compare how many people are infected in each group.
    • Post-market surveillance: The surveillance that occurs after a vaccine or drug has been approved and regularly prescribed by doctors. This monitoring usually confirms that the treatment is safe. Rarely, side effects are noted in certain groups of people that were overlooked during clinical trials.
    • Preclinical Research: Studies that take place prior to the start of a clinical trial typically include experiments that test a treatment on cells or animals.
    • Viral vector vaccines: A type of vaccine that uses a harmless virus to deliver immune-stimulating ingredients into the human body. Viral vectors are used in several experimental Covid-19 vaccines, including those developed by AstraZeneca and Johnson & Johnson. Both companies use a cold virus called adenovirus as a vector. The adenovirus carries coronavirus genes.
    • Test protocol: A series of procedures that must be performed during a clinical trial.

The educational materials also provide a deeper look into the safety of the vaccine. In any large clinical trial, some people who receive vaccines have health conditions unrelated to the vaccine itself. Comparing their symptom rates with those of the placebo group, as well as background rates in a population, may indicate symptoms that a vaccine may actually cause.

The FDA concluded that there were no “significant imbalances” between the two groups in serious health complications known as adverse events. The agency found that four people in the vaccinated group had a form of facial paralysis called Bell’s palsy, with no cases in the placebo group. The difference between the two groups was not significant and the rate in the vaccinated group was not significantly higher than in the general population.

The new Pfizer analysis found that many volunteers who received the vaccine felt sick in the hours after the second dose, suggesting that many people may need to request a day off or be willing to rest until symptoms appear ease up. Among the 16 to 55 year olds, more than half developed fatigue and more than half also reported headaches. Slightly more than a third experienced chills and 37 percent had muscle pain. About half of those over 55 felt tired, a third had a headache, and about a quarter felt chills, while 29 percent had muscle pain.

“Taking a day off after the second dose is a good thing to anticipate,” said Dr. Iwasaki.

On Monday, Kristen Choi, a psychiatric nurse and health care researcher at the University of California at Los Angeles, released a firsthand report on the symptoms she experienced as a participant in the Pfizer BioNTech study, including chills, nausea and headaches and fever.

“Doctors need to be prepared to discuss with patients why they should trust the vaccine and that its adverse effects could be very similar to Covid-19,” wrote Dr. Choi in JAMA Internal Medicine. She advised doctors to tell patients that these uncomfortable symptoms “are a sign that the vaccine is working despite the unfortunate similarities with the symptoms of the disease”.

Categories
Business

Warner Bros. CEO defends 2021 movie launch mannequin, in talks with expertise

Last week, AT & T’s Warner Bros. announced that all films set to release in 2021 will be released on HBO Max as soon as they hit theaters. Ann Sarnoff, chairman and CEO of Warner Bros. Entertainment, defended the decision on Tuesday.

“We have been trying to find the best way forward for the last eight months since we were first suspended,” Sarnoff told CNBC’s Julia Boorstin on Squawk Alley. “We have a lot of movies that are ready and they’re on the shelves, so we thought this was the most creative and win-win situation to get them not only in theaters but also on HBO Max for 31 days at the same time . “

Like many film studios, Warner Bros. has been forced to postpone blockbuster features due to the coronavirus pandemic. Now they are looking for a way to get theatrical releases but also improve the HBO Max streaming service.

However, the company’s decision was not well received by many filmmakers or cinema chains. Warner Bros. has not consulted with the actors, agents, or directors of the 17 films that make up the 2021 film, and has not entered into distribution agreements with cinemas that have traditionally opposed simultaneous theatrical and streaming releases.

Indeed, some media reports suggest that filmmakers and cinema owners were only informed of the announcement less than two hours before it was released.

In addition, the New York Times reported that “Wonder Woman 1984” star Gal Gadot and director Patty Jenkins were each rewarded with a check for $ 10 million when Warner Bros. decided to send that film to HBO Max if it came to Christmas is coming to theaters. This was seen as minor to other talents who had worked with the company.

“It’s a unilateral decision that the studio made,” Christopher Nolan, a notable filmmaker and contributor to Warner Bros., told the Associated Press on Monday. “You didn’t even tell anyone involved. You have these great filmmakers who have worked passionately and diligently for years on projects that are supposed to be feature films with fantastic movie stars. And everyone has now been told it is a loss leader for a boy Streaming service. “

Nolan is known to pressure Warner Bros. to release his movie “Tenet” on the big screen instead of offering it for purchase as a premium video upon request. As of August, Tenet has had domestic sales of $ 57.6 million and $ 302.1 million from international markets.

“We work through the system with our talent and their agents,” said Sarnoff. “I think the more they see how well they’re getting paid, the more we find that people understand the economy. And that’s unprecedented. So it’s always a bit difficult to work something new through for the first time.”

Sarnoff did not disclose details of financial dealings with parties, but said filmmakers and talent “have access to some additional economic aspects of HBO Max.”

“We are in the process of having a lot of conversations with the talent, agents and exhibitors to see how this can work and be good for everyone,” she said.

Currently, that same-day movie release strategy in theaters and on HBO Max only appears to apply for 2021. Sarnoff called it a “workaround” but said the company needs to see how 2022 plays out before making any decisions about future sales models.

Jason Kilar, CEO of WarnerMedia, made similar comments in an interview with CNBC last week.

“Everyone should take a breather,” said Kilar. “Let’s play for the next six, eight, ten months. And then let’s check in again.”

AT&T CEO John Stankey said earlier Tuesday that the streaming service had added subscribers even before the new content hit the service. HBO Max has approximately 12.6 million subscribers, up from 8.6 million activated accounts at the end of the third quarter.

Categories
Health

Some States Balk After C.D.C. Asks for Private Knowledge of These Vaccinated

“This is a new activity for us because we don’t typically report this level of detail to the federal government at this frequency,” Doug Schultz, a spokesman for the Minnesota Department of Health, said in an email. He added, “We will not provide a name, zip code, race, ethnicity or address.”

Tracking vaccinations, including collecting personal information, is not a new practice, and experts say this is especially important with a vaccine that requires two doses. But in the United States, it was a purely state effort. A push two decades ago to develop a federal registry that imploded after an uproar over patient privacy and the use of the data.

“The general philosophy in this country is that states manage public health. Therefore, the concept that we keep track of identified information at the federal level is important,” said Dr. Shaun J. Grannis, professor of medical informatics at Indiana University, who advised the CDC on data collection.

“We are 50 different states with a patchwork of regulations and different perspectives on privacy and security,” added Dr. Grannis added. “And I think people will ask the question: what does the CDC do that we cannot do regionally?”

However, the state registers differ in terms of sophistication and quality. Speaking at Monday’s briefing, Colonel RJ Mikesh of the Army, the information technology director for Operation Warp Speed, said the data collection was part of an “all America approach” to vaccine distribution.

And some experts say that amid a pandemic that has already cost nearly 284,000 lives in the US, privacy must give way to the public good and that vaccinating all Americans is a monumental task that requires federal intervention.

“We’re in a pandemic,” said Dr. Carlos del Rio, an infectious disease expert at Emory University in Atlanta. “Privacy has its role, but it can’t be what drives decision-making when you’re trying to do a monumental task like vaccinating millions of Americans with one vaccine that requires two doses.”

Categories
Politics

Checks, legal responsibility amongst aid disagreements

U.S. Senate Majority Leader Mitch McConnell (R-KY) arrives for the press conference after the weekly Senate Republican Caucus Politics lunch on Capitol Hill in Washington.

Jonathan Ernst | Reuters

Congress attempted an elusive coronavirus relief deal Tuesday as known barriers stood in the way of aid to Americans struggling to cover food and housing costs.

Washington leaders hope to pass a bailout before the end of the year after months of inactivity. If no further aid is sent by then, unemployment benefits for around 12 million people can be cut and millions of people threatened with eviction.

To reach an agreement in time, Republicans and Democrats must resolve even bigger disputes over corporate liability protection, state and local government relief, and direct payments to Americans. Legislators plan to buy more time to reach both pandemic relief and spending agreements by passing a week-long rolling resolution to keep government funding going through December 18.

A non-partisan group worked for days to produce a $ 908 billion compromise bill. Legislators intend to release more details on the proposal on Tuesday afternoon.

While the Democrats have adopted the plan as a basis for talks with Republican leaders, Senate Majority Leader Mitch McConnell, R-Ky., Has continued to call for a “targeted” bill of around $ 500 billion. According to Bloomberg, he plans to meet with Kevin McCarthy, R-Calif., Treasury Secretary Steven Mnuchin, and White House Chief of Staff Mark Meadows to discuss the development of stimulus plans.

A daily average Covid-19 infection rate of more than 200,000 has overwhelmed hospitals across the country. States and cities have put new economic restrictions in place to slow cases in an already sluggish economy where around 20 million people are receiving unemployment benefits.

Where the plans are

Congress leaders have signaled that they want to incorporate coronavirus control measures into spending legislation. The move would allow Congress to approve both must-pass invoices in one fell swoop.

Getting an agreement on both fronts is the hard part.

The bipartisan plan, as first outlined last week, would invest nearly $ 300 billion in paycheck protection program small business loans and $ 160 billion in support from state and local governments who may have to lay off workers. It would reintroduce the federal unemployment insurance surcharge at $ 300 per week and provide funding for the distribution, education, and transportation of Covid-19 vaccines, among other things.

The proposal originally presented would also give companies temporary federal liability for coronavirus-related lawsuits until states enact their own laws. However, negotiators have not yet decided how to produce the final text on legal protection and state and local aid, West Virginia Democratic Senator Joe Manchin said Tuesday.

McConnell has insisted on including liability coverage in an aid package. His narrower approach includes this provision along with PPP loans and vaccine distribution and education funds. He has spoken out against new state and local easements.

Chuck Schumer, Chairman of the Senate Minority, DN.Y., spoke in the Senate on Tuesday calling on the GOP to abandon the demand for legal immunity.

“The situation is really quite simple,” he said. “There are blatant needs across the country and we have to work across party lines to pass laws that meet those needs.”

Stimulus checks have turned out to be a problem in an aid agreement. Two senators – Vermont independent Bernie Sanders and Missouri Republican Josh Hawley – have signaled they oppose a package that doesn’t include direct payments to families.

House spokeswoman Nancy Pelosi, D-Calif., Told Bloomberg Tuesday that she would like to continue to want stimulus checks in an agreement. She said the question of including her was “really a matter for the president,” the news agency said.

On Tuesday, Politico reported that the Trump administration would push for direct payments in aid legislation. At the same time, McConnell’s opposition to the provision is “softening,” according to the report.

Subscribe to CNBC on YouTube.

Categories
Entertainment

Two Ailey Stars Will Now Flip Their Focus to Child Steps

Glenn Allen Sims and Linda Celeste Sims did what many couples do: they had a baby. But they are no ordinary couple.

Two esteemed veterans of the Alvin Ailey American Dance Theater – Glenn for 23 years and Linda for 24 years – they have long held onto jobs that have pushed them to their physical limits. With the birth of their son Ellington James Sims in April 2019, they faced a new challenge.

Your last season in the city center in December 2019 was exhausting – not that you knew it from her dance: refined, passionate and, as always, full of life. Your coping mechanism? “We went to the theater and fell asleep,” said 45-year-old Sims in a joint interview with Ms. Sims. “We’d take a nap in our locker room.”

At the time, Ellington – now nearly 20 months old and chirping happily in the background – did not sleep through the night. Originally, our plan was to keep dancing and staying with the company, ”said Ms. Sims, 44 years old. “But at Ailey, traveling is really the problem.”

It is not just the dancing that ailey dancers require; It’s the tour that can take five months or more in a normal year. When they decided to retire before the outbreak of the pandemic, one question became increasingly easy to answer: “Are we taking him on the streets?”

“Why should I raise my child in a hotel?” Ms. Sims said. “And don’t get me wrong – two weeks, three weeks on tour? It can be done. But not months at a time. It was like we needed the best for the baby. “

In this virtual Ailey season, the couple’s farewell performance will be shown on Wednesday, which includes a number of video clips from their repertoire. as well as a new film about the romantic central duet in “Winter in Lisbon”, a solemn work by Billy Wilson on Dizzy Gillespie; and a discussion with the couple, led by choreographer Ronald K. Brown. But it’s not that they’ll never dance again.

“Guest artist?” Ms. Sims said. “I’ll be there when you need me. Or occur for certain special events. “

Mr. Sims, who said his career was spent in minimal clothing, won’t miss the form-fitting full body.

Shortly before the January pandemic, the couple moved from New Rochelle to a home in Mahopac, NY, where Ms. Sims teaches at Marymount College, Ballet Hispánico, and Ailey Extension.

Mr. Sims is pursuing a degree from SUNY Empire State College, where his focus is on performing arts management. Oddly enough, the timing of her decision to retire from Ailey during the pandemic has proven itself. “We were able to walk and didn’t feel the pressure of having to be at work during that time,” said Ms. Sims.

When life returns to normal, Ms. Sims will become the rehearsal director for Ballet Hispánico, where she trained and danced. Mr. Sims is in talks to become the company’s head.

“I don’t feel like I’m leaving anything or my career has not fulfilled,” Ms. Sims said. “I feel very well nourished and fed. And I still have a feeling that there could be another story. “

Their story first began in Ailey, where they met and secretly dated. “We were really, really young – 19 and 20,” Ms. Sims said. “We wanted to keep the space where we are professional at work. No love dove stuff. “

They married in 2001 and eventually started being cast together. Sometimes couples don’t have the same chemistry on stage, but their partnership has been a striking example of support and sophistication. In the most regal and inconspicuous way both remained in the service of the choreography and showed themselves in their full strength.

While Ailey has given them a lot – in addition to traveling the world, they’ve each danced in nearly 100 works over the years – Mr. Sims can pinpoint exactly what he’s missed: family. “Our family has always been a part of us and around us, but now there are more ways to just talk to them when I feel like I want to talk to them,” he said. “And now we have our own.”

What follows are edited excerpts from a current interview.

You just shot “Winter in Lisbon” for the virtual gala last month. What does this achievement say about you?

GLENN We are today.

LINDA The second time I saw it, I thought, my goodness, how many people can actually say they dance like that at 44? As dancers we are so hard on ourselves that we forget that we have to be thankful too. And so I am very grateful that, even after having a child, I can still do the things that I can physically do.

What did you notice when you were actually on stage in your last season in New York together?

LINDA Being away from the stage for a whole year felt different. I thought I hope I fit into all of my costumes. And I did! But to be on stage with Glenn was just wonderful. Dancing fixed me. We made many “revelations” and the way I would hear the music would be different. I just felt very mature.

GLENN I was more attuned to my body, but I heard more nuances in music because my life was full of nuances.

LINDA I cried”. [The Ailey solo is dedicated “to all Black women everywhere — especially our mothers.”] I had two chances to play it in the season and the first time I had so much to say – like when you want to eat something and eat it that fast, but you didn’t have time to enjoy it. I didn’t let it simmer. So I thought what are you holding back What are you afraid of? Why don’t you just do it

How did that feel

LINDA It was all. I think I cried the whole thing. I don’t know what it looked like! [Laughs] Sometimes ugliness can be beautiful; I allowed myself to be so vulnerable. There’s the whole experience of childbirth and – women don’t talk about it – how exhausting [motherhood] is. There are really ugly moments when it’s not just joy. It’s like your baby has been born, you will feel this joy and love. And it is like that, no, it doesn’t always happen all the time. I thought I will talk about it. [Laughs]

They weren’t planning to have children. What changed your mind

LINDA In Europe we always went sightseeing with the company and I saw these families. I got the urge to get. It was pretty much like that when I turned 40. I feel complete with Glenn so I don’t want this to sound wrong, but I still felt like something was missing.

GLENN And I gave her those crazy eyes because then you have to look around. … I looked around our apartment and thought, OK, everything will change. The art on the wall, the glass table. How will it work financially? I started to freak out. It’s something I’ve wanted for a long time, but I never wanted to put pressure on Linda about children. Ever.

LINDA And that’s a nice thing. After 18 years of marriage, we had Ellington.

Are you obsessed with Duke Ellington?

LINDA No! We weren’t obsessed at all. But one of the pieces that I think we sculpted on stage every time we performed was “The River”. [set to Ellington]. The musicality, the choreography of Mr. Ailey – it’s just one of our favorite pieces. We fell in love with [Ellington’s] Music; It’s not that we hear it every day, but we can actually perform with its music. So we just thought, how do we find a name that connects the two of us but is also unique enough to be itself?

GLENN It’s also about the partnership Ailey had with Duke Ellington and the way we met – through Ailey. It was something we could always carry with us. So how do we honor our own careers and our son? With a great name.

Categories
World News

Britain rolls out the Pfizer vaccine, an enormous process however an indication of hope.

The UK’s National Health Service delivered its first footage of the Pfizer BioNTech Covid-19 vaccine on Tuesday. He opened a mass vaccination campaign with little precedent in modern medicine, making the British the first in the world to receive a clinically approved, fully tested vaccine for the disease.

Vaccine centers across the country are starting to carefully deliver vaccinations on a tight schedule, as the vaccine must be used or thrown away within five days of being thawed. “We do this with military precision, and indeed the military helped us with our planning,” said Fiona Kinghorn, who oversaw the launch of the vaccine at a site in Cardiff, Wales.

The effort marks a turning point in the remarkable race to manufacture a vaccine and global effort to end a pandemic that killed 1.5 million people worldwide. At a Welsh vaccination center, a retired nurse on the facility described the reaction of her youngest patient, another nurse. “She just cried and said it was such an emotional day,” she said, adding, “I think partly because she worked on a Covid ward so she saw the consequences and probably the results. Me assume she saw a lot. “

At 6:31 am Tuesday, 90-year-old Margaret Keenan, a former jeweler, rolled up the sleeve of her Merry Christmas T-shirt for the first shot, and her image quickly became a symbol of hope and resilience .

“I feel so privileged to be the first person to be vaccinated against Covid-19,” said Ms. Keenan, who lives in Coventry, Central England. “That means I can finally look forward to spending time with family and friends in the New Year after being alone for most of the year.”

UK regulators jumped ahead of their American counterparts last week to approve a coronavirus vaccine, which angered the White House and sparked a lively debate over whether the UK had moved too quickly or whether the United States was wasting valuable time when the virus was around 2,200 People killed Americans one day in the past week, as of Monday.

President Trump planned on Tuesday to issue an executive order proclaiming that other nations will not receive US vaccines until after Americans are vaccinated. This guideline seemed to have no real teeth, but it was indicative of the heated race to secure dose deliveries.

For the people who were vaccinated in the UK, including doctors and nurses who joined the country’s National Health Service this year, the footage was an early glimpse into life after the pandemic. Except for Ms. Keenan, none got as much attention as William Shakespeare, who was second in a shot in Coventry and whose real name, the National Health Service confirmed, is William Shakespeare. Twitter used the news of his vaccination as an opportunity for an enthusiastic play on words and jokes about the taming of the flu and the gentlemen of Corona.

“Today is a great day for medicine and the future,” said Chris Whitty, chief medical officer for England, on Tuesday. (A previous version of this article incorrectly stated that he was the chief medical officer for the whole of the UK.)

The first 800,000 doses of Pfizer BioNTech vaccine for the UK have been shipped from a manufacturing facility in Belgium to government warehouses in the UK and then to hospitals in the past few days.

50 hospitals will manage the admissions until the government can refine a plan for delivery to nursing homes and doctor’s offices. The vaccine must be transported in temperatures similar to the south pole before it can be stored in a regular refrigerator for five days, Pfizer said. Doctors and nurses, certain people aged 80 and over, and nursing home workers are given the vaccine first.

Some doctors and nurses have received invitations to register for appointments in the past few days. The first shots are for those who are at the highest risk of serious illness. The government has indicated that people aged 80 and over who have already had a doctor’s visit or are discharged from certain hospitals for this week will also be among the first to receive gunfire.

Nursing home residents, who should actually be the government’s top priority, will be vaccinated in the coming weeks once health officials start distributing doses across hospitals.

Hundreds of people are still dying from the virus every day in the UK, and the country has taken into account Christmas travel that scientists fear will trigger another surge in infections.

“It’s amazing to see the vaccine, but we can’t afford to relax right now,” British Prime Minister Boris Johnson said Tuesday morning when visiting a London hospital. Trying to calm a recipient’s nerves over needles, he suggested, “I always try to think of something else – recite poetry.”

Ms. Keenan, the first vaccine recipient, showed no such nerves. Nicola Sturgeon, Scotland’s first minister, said on Twitter that she had “a little lump in her throat” when Ms. Keenan was shot.

“Feels like a milestone after a tough year for everyone,” added Ms. Sturgeon.

Ms. Keenan’s shot was administered by May Parsons, a nurse originally from the Philippines who has worked for the National Health Service for 24 years.

“The past few months have been difficult for all of us who work in the NHS,” she said, “but now it feels like there is light at the end of the tunnel.”

Categories
World News

Apple could take away apps that observe customers with out permission in 2021

Craig Federighi, Apple’s senior vice president of software engineering, speaks during a new product announcement at the Apple Worldwide Developers Conference on Monday June 4, 2018 in San Jose, California.

Marcio Jose Sanchez | AP

Starting next year, Apple will be removing apps from its app store that are tracking users without prior permission. This promises to strengthen iPhone users’ privacy but is likely to shake the app advertising industry.

To target advertisements and measure their effectiveness, app developers and other industry players currently often use an IDFA (Identifier for Advertisers) or a sequence of letters and numbers that is different on each Apple device.

In an update to the iPhone operating system, which is expected “early next year,” app manufacturers must ask for permission to access a user’s IDFA via a popup. A significant proportion of users will likely choose to opt out, which will reduce the effectiveness and profitability of targeted ads. The change takes a privacy option that was previously buried in Settings and brings it to the fore when users open each app.

On Tuesday, Craig Federighi, Apple’s senior vice president of software development, said apps that do not meet the new requirements that Apple calls App Tracking Transparency (ATT) can be removed from the App Store. This is the only way to install software on an iPhone.

The move puts app developers who make money from targeted ads versus Apple, which has increasingly built privacy features into its products to set them apart from the competition. Among the critics is Facebook, which said the change could cut sales in one of its advertising stores by 50%.

“Some in the advertising industry are opposing these efforts, claiming that ATT will cause ad-supported businesses to suffer dramatic damage. However, as with the introduction of intelligent tracking prevention, we expect the industry to adapt and deliver effective advertising without invasive tracking “said Federighi in a speech at a European data protection conference.

Some examples of the tracking that Apple says app makers would need to get user permission first:

  • Show targeted advertisements in apps based on user data collected from apps and websites of other companies.
  • Share device location data or email lists with a data broker.
  • Share a list of emails, promotional IDs, or other IDs with a third-party ad network that will use the information to refocus those users in other developer’s apps or find similar users.

“Early next year we will need any apps that want to do this in order to get explicit permission from their users, and developers who do not meet this standard can have their apps removed from the App Store,” said Federighi.

The disclosure that Apple can remove non-compliant apps also raises the stake for a date expected early next year when app developers will have to specifically ask permission to use IDFA to perform tracking, forcing developers to rebuild part of their ad targeting systems to meet Apple’s requirements.

According to StatCounter, Apple’s iPhones make up just over 25% of smartphones worldwide, but the market share is higher in countries like the United States. In addition, iPhone users are often wealthier and viewed as more valuable customers. When app developers are removed from the app store, they lose a huge market.

Apple’s ATT is the latest in a series of steps reducing advertisers’ ability to collect data about iPhone users. In 2017, Apple introduced a feature called ITP that uses machine learning to block ad trackers in the Apple Safari browser. On Tuesday, Apple asked app developers to submit a detailed questionnaire about its privacy practices and the data they and third-party partners collect before being approved on the App Store.

Apple has been criticized on both sides of the IDFA issue. In France, advertising firms and publishers filed a competition complaint in October alleging that the proposed move away from IDFA is using privacy as cover for anti-competitive behavior to harm smaller tech companies.

Last month, Apple was also hit by complaints from activists in Europe that IDFA – the current system – did not comply with European data protection laws.

“We have postponed the release of ATT until early next year to give developers the time they have given to properly update their systems and data practices. However, we are still fully committed to ATT and our comprehensive approach to privacy obliged, “said Jane Horvath, senior data protection officer at Apple, replied.

Apple has not publicly announced when ATT will take effect.

Categories
Entertainment

Romantic Christmas Motion pictures on Netflix | 2020

The holiday season is all about love: love for family, love for friends, and maybe even the kind of love that ends under the mistletoe. It’s no wonder so many films about the Christmas season feature romantic storylines – according to romance films, snow is the only thing more romantic than rain. Romantic Christmas films are not limited to television films that cable networks produce each year. In fact, there are some of the cutest Christmas movies out there in decades! If you’re looking for a movie that hits the sweet spot of vacation magic and impotent romance, you’ve come to the right place. Read on to find a movie as romantic as it is festive to stream this winter.

– Additional coverage from Lauren Harano

Categories
Politics

What We Know In regards to the Voting in Georgia So Far

The deadline for registering to vote in the runoff elections in Georgia expired Monday, bringing the state closer to personal voting in two crucial Senate races.

The January 5 contests will determine whether two Republican incumbents, Senators David Perdue and Kelly Loeffler, will keep their seats. If their Democratic challengers Jon Ossoff and Rev. Raphael Warnock both win, the Democrats will claim control of the Senate.

Now it’s all up to the Georgia voters. Here’s a look at the next steps.

Some voters are already casting ballots in the runoff elections – the state started sending postal ballots last month. The personal early voting begins on December 14th. It happens to be the same day that members of the electoral college will officially vote for Joseph R. Biden Jr.

Georgians are increasingly choosing to cast their ballots early and by post. Almost a million voters have already requested postal ballot papers for the run-off elections, according to state election officials, including more than 600,000 people who were entitled to receive the ballot automatically.

According to the Georgian Secretary of State, more than 1.3 million voters cast postal votes in November’s parliamentary elections. But more than 71,000 people who did not vote in the general election have requested ballot papers for the runoff ballot, according to state data compiled by Ryan Anderson, a data analyst in Atlanta.

So far, according to the State Secretary, around 43,000 Georgians have returned their postal votes for the runoff election. About 1,000 of these voters did not cast ballots in the general election. Postal ballot papers must be requested by January 1st and received by January 5th to count. However, voters should act earlier to avoid delays in the mail.

Both parties encourage their voters to cast their ballots early. Democrats hope to retain an advantage that helped their party beat President Trump in the November election when Mr Biden won nearly 400,000 more postal ballots in the state.

Republicans are trying to fill that void because they fear January weather and the worsening coronavirus pandemic could keep some of their constituents at home on election day. After months of Mr Trump’s disinformation campaign against postal voting, his own party has begun targeting its constituents in Georgia with leaflets and digital ads asking them to request postal voting.

Not all Republicans in Georgia are convinced: when Vice President Mike Pence encouraged voters to vote by post while the state was on a campaign freeze, he encountered a few boos, according to the Atlanta Journal constitution.

Runoff elections have traditionally been relatively sleepy competitions with a lower turnout that favored Republicans due to a drop in Democrats after the general election. (The runoff election itself was developed by white Georgians in the 1960s to dilute the power of black voters.)

Not this year. A flotilla of high-performing political stars has already entered the race, including former President Barack Obama and Mr. Trump. Mr Biden is expected to fight for the Democrats just before election day.

Television advertising prices are rising amid an astonishing influx of political spending. Hundreds of millions of dollars will be spent on the two races before January 5th.

The stakes couldn’t be higher: Senate control will effectively set the parameters of Mr Biden’s first term. A Republican-led Senate would make it difficult for him to fill his cabinet, pass laws, and advance his political priorities.

Both parties expect a significantly higher turnout than in the last Senate runoff in 2008, although few analysts expect numbers close to the five million voters who voted in last month’s general election.

Modeling the electorate is not easy: never before has a runoff election in Georgia determined the balance of power in the Senate – or has it been held in the middle of a pandemic.

In November, Mr Perdue received 49.7 percent of the vote, just below the majority he would have needed to avoid a runoff, while Mr Ossoff had 47.9 percent, a difference of about 88,000 votes. The field was overcrowded in the other Senate competition: Mr. Warnock finished with 32.9 percent of the vote and Ms. Loeffler with 25.9 percent.

Democrats see opportunities in the changing demographics of the state. The drive to reach new voters, led by Stacey Abrams, drew an estimated 800,000 residents to vote – a wave that helped propel Mr. Biden’s victory in Georgia.

Republicans believe that some voters who supported Mr Biden will want a review of democratic power in Washington. However, their efforts were hampered by Mr. Trump’s refusal to end the previous competition.

Some Republican strategists fear that Mr Trump’s attacks on the presidential election results will hamper their efforts to win back some of the suburban moderate voters who fled their party in November.

A fringe group of conservative voters is also encouraging Republicans to boycott the election in support of Mr Trump’s baseless claims of fraudulent vote counting that could undermine Republican margins.

The Georgia State Election Board extended some emergency provisions from the November election, such as the retention of dropboxes for postal ballot papers. Some of the rules have been adjusted to encourage faster counting as the new Congress is expected to be sworn in on January 3rd.

Districts must now start scanning and processing ballot papers at least a week before the election, but cannot start counting or tabulating until election day. These new rules should result in faster results starting on election night, though a close race will almost certainly end in recounts and litigation.

Some Democrats and voting rights groups have raised concerns about access to voting and possible repression.

Electoral officials in Cobb County, Georgia’s third largest county, plan to open fewer than half of the general election polling stations, reducing the number from 11 to five.

Some of the locations that are being closed, like the Smyrna Community Center in Smyrna, are in neighborhoods with large black populations. Voting and civil rights groups sent a letter to the district election officer on Monday asking her to keep all eleven locations open.

Categories
Health

Shares of Penumbra tank after brief vendor releases important report

Penumbra’s shares were down about 17% Tuesday after short seller Quintessential Capital Management released a critical report on the California-based medical device maker. The stock halted shortly after 2 p.m. ET due to outstanding news.

Quintessential Capital is short in Penumbra, which means they are betting that the stock will fall. The company first began targeting penumbra last month, releasing a report of more than 100 slides claiming, among other things, its JET 7 catheter had been linked to at least 18 deaths and 39 injuries. Quintessential Capital also alleged penumbra misled doctors and investors alike.

In its most recent report, Quintessential Capital claims that an “essential part” of the company’s scientific research was carried out by a fake person named Dr. Antique Bose. “This person is a fake. We have no doubts,” said Gabriel Grego, managing partner of Quintessential Capital, on Tuesday in CNBC’s “mid-term report”.

Quintessential Capital directed its allegations of misconduct to the US Food and Drug Administration and wrote to the regulator on Tuesday to open an investigation. According to records that Grego shared with CNBC, the company has also given the SEC a whistleblower tip.

Penumbra has a market cap of around $ 7 billion as of Tuesday afternoon. At the time of Quintessential Capital’s November report for the company, its market cap was approximately $ 9.4 billion.

In a statement accompanying the Mid-Term Report, Penumbra denied Quintessential Capital’s claims, saying that its “innovative medical devices have helped save the lives of hundreds of thousands of patients suffering from life-threatening diseases since its inception in 2004”.

“This attack by bad QCM short sellers reads like an internet conspiracy written by teenagers. It is impossible to deny the facts because there are no facts,” the company said in an email. “Penumbra is very comfortable finding that none of the claims made in the diatribe of these short sellers are true. The claims are nothing more than a baseless campaign of shameless short sellers willing to risk lives for a quick profit. “

– CNBC’s Lora Kolodny contributed to this report.